| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| MEF2D - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN408748 | 1 kit | ORIGENE TECHNOLOGIES |
| Mouse hepatocyte growth factor (Hgf). from ORIGENE TECHNOLOGIES | TP723157 | 20 ug | ORIGENE TECHNOLOGIES |
| PAIP2B - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN419314 | 1 kit | ORIGENE TECHNOLOGIES |
| Paip2b - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN512761 | 1 kit | ORIGENE TECHNOLOGIES |
| PAIP1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN402038 | 1 kit | ORIGENE TECHNOLOGIES |
| PAIP2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407342 | 1 kit | ORIGENE TECHNOLOGIES |
| Paip1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN512759 | 1 kit | ORIGENE TECHNOLOGIES |
| Paip2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN512760 | 1 kit | ORIGENE TECHNOLOGIES |
| Human ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 (ACAP1) from ORIGENE TECHNOLOGIES | TP303724 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 (ACAP2) from ORIGENE TECHNOLOGIES | TP309171 | 20 ug | ORIGENE TECHNOLOGIES |
| Paired box 2 (PAX2), transcript variant a from ORIGENE TECHNOLOGIES | LY429172 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 2 (PAX2), transcript variant a from ORIGENE TECHNOLOGIES | LY418300 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 2 (PAX2), transcript variant b from ORIGENE TECHNOLOGIES | LY400106 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 7 (PAX7), transcript variant 3 from ORIGENE TECHNOLOGIES | LY427610 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 2 (PAX2), transcript variant c from ORIGENE TECHNOLOGIES | LY418301 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 2 (PAX2), transcript variant d from ORIGENE TECHNOLOGIES | LY418302 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 2 (PAX2), transcript variant e from ORIGENE TECHNOLOGIES | LY429174 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 3 (PAX3), transcript variant PAX3 from ORIGENE TECHNOLOGIES | LY430530 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 2 (PAX2), transcript variant e from ORIGENE TECHNOLOGIES | LY418303 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 3 (PAX3), transcript variant PAX3 from ORIGENE TECHNOLOGIES | LY405766 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 8 (PAX8), transcript variant PAX8A from ORIGENE TECHNOLOGIES | LY401173 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 8 (PAX8), transcript variant PAX8C from ORIGENE TECHNOLOGIES | LY415550 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 3 (PAX3), transcript variant PAX3D from ORIGENE TECHNOLOGIES | LY405767 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 8 (PAX8), transcript variant PAX8D from ORIGENE TECHNOLOGIES | LY415551 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 8 (PAX8), transcript variant PAX8D from ORIGENE TECHNOLOGIES | LY429388 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 3 (PAX3), transcript variant PAX3E from ORIGENE TECHNOLOGIES | LY430531 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 3 (PAX3), transcript variant PAX3E from ORIGENE TECHNOLOGIES | LY405768 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 8 (PAX8), transcript variant PAX8E from ORIGENE TECHNOLOGIES | LY415574 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 8 (PAX8), transcript variant PAX8E from ORIGENE TECHNOLOGIES | LY429402 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 3 (PAX3), transcript variant PAX3G from ORIGENE TECHNOLOGIES | LY405770 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired box 3 (PAX3), transcript variant PAX3G from ORIGENE TECHNOLOGIES | LY430533 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired immunoglobin-like type 2 receptor alpha (PILRA), transcript variant 1 from ORIGENE TECHNOLOGIES | LY415539 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired immunoglobin-like type 2 receptor alpha (PILRA), transcript variant 3 from ORIGENE TECHNOLOGIES | LY405991 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired immunoglobin-like type 2 receptor beta (PILRB), transcript variant 1 from ORIGENE TECHNOLOGIES | LY415540 | 100 ug | ORIGENE TECHNOLOGIES |
| Paired immunoglobin-like type 2 receptor beta (PILRB), transcript variant 2 from ORIGENE TECHNOLOGIES | LY406375 | 100 ug | ORIGENE TECHNOLOGIES |
| SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae) (SPTY2D1) from ORIGENE TECHNOLOGIES | LY405123 | 100 ug | ORIGENE TECHNOLOGIES |
| SPTY2D1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN423508 | 1 kit | ORIGENE TECHNOLOGIES |
| Spty2d1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516691 | 1 kit | ORIGENE TECHNOLOGIES |
| B-cell CLL/lymphoma 7A (BCL7A), transcript variant 2 from ORIGENE TECHNOLOGIES | LY422541 | 100 ug | ORIGENE TECHNOLOGIES |
| B-cell CLL/lymphoma 11A (zinc finger protein) (BCL11A), transcript variant 1 from ORIGENE TECHNOLOGIES | LY411466 | 100 ug | ORIGENE TECHNOLOGIES |
| B-cell CLL/lymphoma 11A (zinc finger protein) (BCL11A), transcript variant 3 from ORIGENE TECHNOLOGIES | LY408578 | 100 ug | ORIGENE TECHNOLOGIES |
| B-cell CLL/lymphoma 7B (BCL7B) from ORIGENE TECHNOLOGIES | LY419788 | 100 ug | ORIGENE TECHNOLOGIES |
| B-cell CLL/lymphoma 7B (BCL7B), transcript variant 2 from ORIGENE TECHNOLOGIES | LY433989 | 100 ug | ORIGENE TECHNOLOGIES |
| B-cell CLL/lymphoma 3 (BCL3) from ORIGENE TECHNOLOGIES | LY417469 | 100 ug | ORIGENE TECHNOLOGIES |
| B-cell CLL/lymphoma 10 (BCL10) from ORIGENE TECHNOLOGIES | LY418351 | 100 ug | ORIGENE TECHNOLOGIES |
| B-cell CLL/lymphoma 2 (BCL2), nuclear gene encoding mitochondrial protein, transcript variant alpha from ORIGENE TECHNOLOGIES | LY424602 | 100 ug | ORIGENE TECHNOLOGIES |
| B-cell CLL/lymphoma 2 (BCL2), nuclear gene encoding mitochondrial protein, transcript variant beta from ORIGENE TECHNOLOGIES | LY424584 | 100 ug | ORIGENE TECHNOLOGIES |
| Human Anus; Carcinoma of anus, squamous cell from ORIGENE TECHNOLOGIES | CS553867 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Anus; Carcinoma of anus, squamous cell, metastatic from ORIGENE TECHNOLOGIES | CS702433 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Anus; Carcinoma of anus, squamous cell, metastatic from ORIGENE TECHNOLOGIES | CS702434 | 5x5um | ORIGENE TECHNOLOGIES |